New ETF Book by Larry Connors - Click here to read more
GE holds 51 per cent stake and the rest is with Wipro in their joint venture, Wipro GE Healthcare, which distributes 85 per cent of GE's various healthcare and medical diagnostic products in India.
"The integration will simplify the structure and help us focus on the Indian market. It will help us in developing new products for India and in entering more markets," GE Chairman and Chief Executive Officer Jeffrey R Immelt said here.
Wipro GE Healthcare will now incorporate units like GE Healthcare Life Sciences, GE Healthcare Medical Diagnostics and GE Medical Systems India.
Immelt said about 20 per cent of the products sold in India are manufactured here and in future the company wants to increase the percentage.
"My view is that over the next 5-10 years, maybe 50-70 per cent of the products sold in India should be developed and manufactured here and some of them eventually would be exported as well," he said.
While the Life Sciences and Medical Diagnostics business units currently distribute GE Healthcare's products outside of Wipro GE Healthcare, GE Medical Systems India manufactures X- ray machines and other diagnostic imaging products and accessories.
On the timeline for completion of the integration, Wipro GE Healthcare President and CEO V Raja said, "It will all depend on courts' approval, in my own assessment it could take anywhere between 6 months to a year, depending on how fast you get the necessary approvals." As part of the integration, about 1,200 employees from GE various healthcare units would be moved into the JV firm, which already has a headcount of 800.
Raja said going forward the JV would continue to add about 200 people annually, which is its average hiring rate.
"There is a huge potential in the Indian medical devices market which is worth about USD three billion and is growing at 12-13 per cent annually. It will continue to grow at this pace if not higher," he said.
The company expects product categories like cardiology (ECG machines), infection treatment (CT and X-Ray) and maternal and infant care (incubators, warmers) to grow faster.
"GE has been our valued partner since 1990. We hope to bring world-class healthcare to South Asia by providing best- in-class solutions," Wipro Chairman Azim Premji said.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
